Lysogene

IPO
Total Funding
$22.0M
Last Round
$22.0M Series AMay 2014
Rounds
1

About

CNS gene therapy for rare neurological diseases

Summary

It has raised $22.0M in total across 1 round, most recently a $22.0M Series A round in May 2014. Investors include Sofinnova Partners and Novo Seeds.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

IPOFeb 2017
$24.8M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors